HROW
HARROW, INC.
Key Financials
Net Income
$-5139000
↑ 70.6%
Gross Profit
$204.4M
↑ 35.9%
Revenue
$272.3M
↑ 36.4%
Operating Income
$30.5M
↑ 245.9%
EPS (Diluted)
$-0.14
↑ 71.4%
Cash & Equivalents
$72.9M
↑ 54.4%
Total Assets
$399.5M
↑ 2.7%
Total Liabilities
$347.4M
↑ 8.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/4/2026 | View on SEC |
| 144 | 8/21/2026 | View on SEC |
| 4 | 8/17/2026 | View on SEC |
| 10-Q | 8/10/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| SCHEDULE 13G/A | 7/31/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HROW |
| Company Name | HARROW, INC. |
| CIK | 1360214 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 615.733.4731 |